Literature DB >> 21292660

The talking Mycobacterium abscessus blues.

David E Griffith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21292660     DOI： 10.1093/cid/ciq252

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  15 in total

1.  Successful treatment of Mycobacterium massiliense lung disease with oral antibiotics only.

Authors:  W-J Koh; K Jeon; S J Shin
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

2.  Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease.

Authors:  Beatriz E Ferro; Shashikant Srivastava; Devyani Deshpande; Jotam G Pasipanodya; Dick van Soolingen; Johan W Mouton; Jakko van Ingen; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus.

Authors:  Rachid Nessar; Jean Marc Reyrat; Alan Murray; Brigitte Gicquel
Journal:  J Antimicrob Chemother       Date:  2011-06-07       Impact factor: 5.790

4.  The first structure of a mycobacteriophage, the Mycobacterium abscessus subsp. bolletii phage Araucaria.

Authors:  Mohamed Sassi; Cecilia Bebeacua; Michel Drancourt; Christian Cambillau
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

Review 5.  Surgical treatment of nontuberculous mycobacterial lung disease.

Authors:  Yuji Shiraishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-17

6.  Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strains.

Authors:  Rebecca M Davidson; Nabeeh A Hasan; Paul R Reynolds; Sarah Totten; Benjamin Garcia; Adrah Levin; Preveen Ramamoorthy; Leonid Heifets; Charles L Daley; Michael Strong
Journal:  J Clin Microbiol       Date:  2014-07-23       Impact factor: 5.948

7.  Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model.

Authors:  Beatriz E Ferro; Shashikant Srivastava; Devyani Deshpande; Carleton M Sherman; Jotam G Pasipanodya; Dick van Soolingen; Johan W Mouton; Jakko van Ingen; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

8.  Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.

Authors:  Go-Eun Choi; Ki-Nam Min; Choul-Jae Won; Kyeongman Jeon; Sung Jae Shin; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

9.  The genome sequence of 'Mycobacterium massiliense' strain CIP 108297 suggests the independent taxonomic status of the Mycobacterium abscessus complex at the subspecies level.

Authors:  Yong-Joon Cho; Hana Yi; Jongsik Chun; Sang-Nae Cho; Charles L Daley; Won-Jung Koh; Sung Jae Shin
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

10.  Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection.

Authors:  Sasha J Rose; Mary E Neville; Renu Gupta; Luiz E Bermudez
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.